skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Development and application of a radioimmunoassay for physostigmine

Technical Report ·
OSTI ID:6010882

Physostigmine, an alkaloid obtained from the Calibar bean, is a cholinergic drug that has been used for memory enhancement in Alzheimer's disease for management of glaucoma and to counter tricyclic poisoning. In addition, military organizations in several countries have an active interest in physostigmine as a pretreatment compound for nerve agent poisoning. Although physostigmine has been used for many years, there has not been a simple sensitive assay to measure low plasma levels associated with therapeutic dosages. Available methods include HPLC assays and capillary column chromatography using chemical ionization mass spectrometry. All of these methods have a number of shortcomings (poor sensitivity, large sample size and time consuming sample preparation) that can be solved with a RIA. We have been able to prepare antibodies to physostigmine that are specific and have a good binding affinity. With these antibodies we have developed a sensitive RIA for physostigmine.

Research Organization:
Army Medical Research Inst. of Chemical Defense, Aberdeen Proving Ground, MD (USA)
OSTI ID:
6010882
Report Number(s):
AD-A-228432/1/XAB; USAMRICD-P-89-005; CNN: DAMD17-84-C-4235
Resource Relation:
Other Information: Pub. in The Jnl. of Pharmacology and Experimental Therapeutics, Vol. 251, No. 2, 606-611(1989)
Country of Publication:
United States
Language:
English